脂質低下と血圧管理が冠動脈プラークに与える影響:経皮的冠動脈インターベンションによる心筋虚血治療並びに脂質低下及び血圧管理治療の血管内超音波画像(MILLION研究)による評価

KAWASHIRI Masa-aki; SAKATA Kenji; HAYASHI Kenshi; GAMOU Tadatsugu; KANAYA Honin; MIWA Kenji; UEDA Kosei; HIGASHIKATA Toshinori; MIZUNO Sumio; MICHISHITA Ichiro; NAMURA Masanobu; NITTA Yutaka; KATSUDA Shoji; OKEIE Kazuyasu; HIRASE Hiroaki; TADA Hayato; UCHIYAMA Katsuharu; KONNO Tetsuo; INO Hidekazu; NAGASE Keisuke; YAMAGISHI Masakazu

文献

J-GLOBAL ID：201702268274310085 整理番号：17A0664186

脂質低下と血圧管理が冠動脈プラークに与える影響:経皮的冠動脈インターベンションによる心筋虚血治療並びに脂質低下及び血圧管理治療の血管内超音波画像(MILLION研究)による評価

Impact of combined lipid lowering and blood pressure control on coronary plaque: myocardial ischemia treated by percutaneous coronary intervention and plaque regression by lipid lowering and blood pressure controlling assessed by intravascular ultrasonography (MILLION) study

出版者サイト複写サービスで全文入手 {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=17A0664186&COPY=1") }}
高度な検索・分析はJDreamⅢで {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0664186&from=J-GLOBAL&jstjournalNo=X0101A") }}

著者 (21件)： , , , , , , , , , , , , , , , , , , , ,
資料名：
巻： 32 号： 5 ページ： 539-548 発行年： 2017年05月
JST資料番号： X0101A ISSN： 0910-8327 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：ドイツ (DEU) 言語：英語 (EN)

日本人の冠動脈疾患(CAD)患者において,低密度リポ蛋白コレ...

,...
,...

続きはJDreamIII（有料）にて {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0664186&from=J-GLOBAL&jstjournalNo=X0101A") }}

脂質代謝作用薬の臨床への応用 , 血管作用薬・降圧薬の臨床への応用 , 循環系疾患の薬物療法

引用文献 (26件)：

Kizer JR, Madias C, Wilner B, Vaughan CJ, Mushlin AI, Trushin P, Gotto AM Jr, Pasternak RC (2010) Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy. Am J Cardiol 105:1289-1296
Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O’Brien E, Ostergren J, Investigators ASCOT (2005) Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required vs. atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 366:895-906
Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, Berman L, Shi H, Buebendorf E, Topol EJ, Investigators CAMELOT (2004) Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 292:2217-2225
SPRINT Research Group, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT (2015) A Randomized Trial of Intensive vs. Standard Blood-Pressure Control. N Engl J Med 373:2103-2116
Kohro T, Yamazaki T, Izumi T, Daida H, Kurabayashi M, Miyauchi K, Tojo T, Nagai R, Investigators JCADII (2011) Intensively lowering both low-density lipoprotein cholesterol and blood pressure does not reduce cardiovascular risk in Japanese coronary artery disease patients. Circ J 75:2062-2070

, , , , , , , ,

前のページに戻る